抗IL-1 Receptor Ⅱ抗体(Anti-IL-1 Receptor Ⅱ, Human, Goat-Poly, Biotin antibody)

掲載日情報:2021/01/28 現在Webページ番号:27533

IL-1 Receptor Ⅱに対する抗体(Anti-IL-1 Receptor Ⅱ, Human, Goat-Poly, Biotin )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-IL-1 Receptor II, Human, Goat-Poly, Biotin
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 3
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
マッチドペア:Human IL-1 RII サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB663-500,スタンダードとして#263-2R-050を用いる。
別名:beta
Genbank No: 7850
Protein Accession No: P27930
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Goat クラス IgG 標識 Biotin
交差性 Human 適用 ELISA,Western Blot
クロナリティ Polyclonal フォーマット 性状 Antigen Affinity Purified 吸収処理
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-IL-1 Receptor II, Human, Goat-Poly, Biotin

文献数: 3

説明文 マッチドペア:Human IL-1 RII サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB663-500,スタンダードとして#263-2R-050を用いる。
別名:beta
Genbank No: 7850
Protein Accession No: P27930
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Goat
交差性 Human 適用 ELISA,Western Blot
標識 Biotin 性状 Antigen Affinity Purified
吸収処理 クラス IgG
クロナリティ Polyclonal フォーマット
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド



目次に戻る

Product Details

Species ReactivityHuman
LabelBiotin
ImmunogenS. frugiperda insect ovarian cell line Sf 21-derived recombinant human IL‑1 RIIPhe14-Glu343 (Ser56Gly and Glu297Gly)Accession # P27930
SourcePolyclonal Goat IgG
PurificationAntigen Affinity-purified
SpecificityDetects human IL-1 RII in ELISAs and Western blots. In sandwich immunoassays, less than 1% cross-reactivity with recombinant human (rh) IL‑1 RI, recombinant mouse (rm) IL‑1 RI, rmIL-1 RII, rhIL-1 RA, rhIL-1 alpha, and rhIL-1 beta is observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Western Blot0.1 µg/mLRecombinant Human IL‑1 RII (Catalog # 263-2R)
Human IL-1 RII Sandwich ImmunoassayReagent
ELISA Capture (Matched Antibody Pair)2-8 µg/mL Human IL‑1 RII Antibody (Catalog #MAB663 )
ELISA Detection (Matched Antibody Pair)0.1-0.4 µg/mL Human IL‑1 RII Biotinylated Antibody (Catalog #BAF263 )
ELISA Standard  Recombinant Human IL-1 RII Protein (Catalog #263-2R )
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website.Preparation and Storage
ReconstitutionReconstitute at 0.2 mg/mL in sterile PBS.Reconstitution Buffer Available
ShippingThe product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-1 RII

Two distinct types of receptors that bind the pleiotropic cytokines IL-1 alpha and IL-1 beta have been described. The IL-1 receptor type I is an 80 kDa transmembrane protein that is expressed predominantly by T cells, fibroblasts and endothelial cells. IL-1 receptor type II is a 68 kDa transmembrane protein found on B lymphocytes, neutrophils, monocytes, large granular leukocytes and endothelial cells. Both receptors are members of the immunoglobulin superfamily and show approximately 28% sequence similarity in their extracellular domains. The two receptor types do not heterodimerize in a receptor complex.

An IL-1 receptor accessory protein that can heterodimerize with the type I receptor in the presence of IL-1 alpha or IL-1 beta but not IL-1ra, was identified (1). This type I receptor complex appears to mediate all the known IL-1 biological responses. The receptor type II has a short cytoplasmic domain and does not transduce IL-1 signals. In addition to the membrane-bound form of IL-1 RII, a naturally-occurring soluble form of IL-1 RII has been described. It has been suggested that the type II receptor, either as the membrane-bound or as the soluble form, serves as a decoy for IL-1 and inhibits IL-1 action by blocking the binding of IL-1 to the signaling type I receptor complex. Recombinant IL-1 soluble receptor type II is a potent antagonist of IL-1 action.

目次に戻る

References

Greenfeder, S. et al. (1995) J. Biol. Chem. 270:13757.
Long Name:Interleukin 1 Receptor II
Entrez Gene IDs:7850 (Human); 16178 (Mouse)
Alternate Names:beta; CD121b antigen; CD121b; IL-1 R beta; IL-1 RII; IL1R2; IL1RBCD121 antigen-like family member B; IL-1R-beta; IL1RII; IL-1RII; IL-1RT2; IL-1RT-2; interleukin 1 receptor, type II; Interleukin-1 receptor beta; MGC47725

目次に戻る

Related Research Areas

B Cell Development and Differentiation
Cytokines and Receptors in Allergy and Asthma
Cytokines and Receptors in Angiogenesis
IL-1 Family
Macrophage Activation Markers
Neuroinflammation
Regulatory T Cells (Tregs)
  1. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production.
    Authors: Emsley HC, Smith CJ, Gavin CM
    BMC Neurol, 2007;7(0):5.
    Species: Human
    Sample Type: Plasma
    Application: ELISA Development


目次に戻る

Related Product & Information

BackgroundIL-1 RII
background_contentBackground:
IL-1 RII
Two distinct types of receptors that bind the pleiotropic cytokines IL-1 alpha and IL-1 beta have been described. The IL-1 receptor type I is an 80 kDa transmembrane protein that is expressed predominantly by T cells, fibroblasts and endothelial cells. IL-1 receptor type II is a 68 kDa transmembrane protein found on B lymphocytes, neutrophils, monocytes, large granular leukocytes and endothelial cells. Both receptors are members of the immunoglobulin superfamily and show approximately 28% sequence similarity in their extracellular domains. The two receptor types do not heterodimerize in a receptor complex. An IL-1 receptor accessory protein that can heterodimerize with the type I receptor in the presence of IL-1 alpha or IL-1 beta but not IL-1ra, was identified (1). This type I receptor complex appears to mediate all the known IL-1 biological responses. The receptor type II has a short cytoplasmic domain and does not transduce IL-1 signals. In addition to the membrane-bound form of IL-1 RII, a naturally-occurring soluble form of IL-1 RII has been described. It has been suggested that the type II receptor, either as the membrane-bound or as the soluble form, serves as a decoy for IL-1 and inhibits IL-1 action by blocking the binding of IL-1 to the signaling type I receptor complex. Recombinant IL-1 soluble receptor type II is a potent antagonist of IL-1 action.


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production.
    Authors: Emsley HC, Smith CJ, Gavin CM
    BMC Neurol, 2007;7(0):5.
    Species: Human
    Sample Type: Plasma
    Application: ELISA Development

  2. Synthesis of type II interleukin-1 receptors by human corneal epithelial cells but not by keratocytes.
    Authors: Cubitt CL, Lausch RN, Oakes JE
    Invest. Ophthalmol. Vis. Sci., 2001;42(3):701-4.
    Species: Human
    Sample Type: Whole Cells
    Application: ICC



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。